Reference range for intrapatient variability in blood-pool and liver SUV for 18F-FDG PET

Journal of Nuclear Medicine

Volumn 54, Issue 5, 2013, Pages 677-682

  Boktor, Raef R ^a   Walker, Gregory ^a   Stacey, Roderick ^a   Gledhill, Samuel ^b   Pitman, Alexander G ^a,c  

^a ST JOHN OF GOD HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Blood pool and liver; Intrapatient variability; SUV

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; AGED; ANALYTICAL PARAMETERS; AORTA; ARTICLE; BLOOD; BODY WEIGHT; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER PATIENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INTRAPATIENT VARIABILITY; LIVER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFERENCE VALUE; REPRODUCIBILITY;

EID: 84877117935     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.108530     Document Type: Article

References (11)

1. Visser EP, Boerman OC, Oyen WJG. SUV: from silly useless value to smart uptake value. J Nucl Med. 2010;51:173-175.
2. Keyes JW. SUV: standard uptake or silly useless value? J Nucl Med. 1995;36:1836-1839.
3. Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. AJR. 2010;195:310-320.
4. Vera P, Ouvrier MJ, Hapdey S, et al. Does chemotherapy influence the quantification of SUV when contrast-enhanced CT is used in PET/CT in lymphoma? Eur J Nucl Med Mol Imaging. 2007;34:1943-1952. (Pubitemid 350212124)
5. Boellaard R, Oyen WJG, Hoekstra CJ, et al. The Netherlands protocol for standardization and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging. 2008;35:2320-2333.
6. Cherry SR, Sorenson JA, Phelps ME. Physics in Nuclear Medicine. Philadelphia, PA: Saunders/Elsevier Science; 2003:423-490.
7. 18F-FDG PET. J Nucl Med. 2010;51:268-276.
8. Anderson H, Singh N, Miles K. Tumour response evaluation with fluorodeoxy-glucose positron emission tomography: research technique or clinical tool? Cancer Imaging. 2010;10(spec no. A):S68-S72.
9. 18F-FDG: standardized uptake values in normal tissues. J Nucl Med. 2004;45:784-788.
10. Pitman AG, Hicks RJ, Kalff V, et al. Positron emission tomography in pulmonary and masses where tissue diagnosis is unhelpful or is not possible. Med J Aust. 2001;175:303-307. (Pubitemid 32888321)
11. Kanstrup IL, Klausen TL, Bojsen-Møller J, Magnusson P, Zerahn B. Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans. Clin Physiol Funct Imaging. 2009;29:108-113.